1Rosenfeld S, Follman D, Nunez O, et al. Antithymocyte globulin and cyelosporine or severe aplastic anemia:association between hematologic response and longterm outcome[J]. JAMA,2003,289(9) :1130 - 1135.
2Friekhofen N, Kaltwasser JP, Schrezenmeier H, et al. Treatment of aplastic anemia with antilymphoeyte globu-lin and methylprednisolone with or without eyelosporine. The German Aplastie Anemia Study Group[J]. N Engl J Med, 1991,324(19):1297 - 1304.
1Judit Demeter,Gerald Messer,Hubert Schrezenmeier. Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia[J] 2002,Annals of Hematology(10):566～569
2S. I. Kapustin,T. I. Popova,A. A. Lyshchov,E. N. Imyanitov,M. N. Blinov,K. M. Abdulkadyrov. HLA-DR4-Ala74β is associated with risk and poor outcome of severe aplastic anemia[J] 2001,Annals of Hematology(2):66～71
